Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and effectiveness of the combination of
oxaliplatin and irinotecan (CPT-11) in patients with previously untreated, advanced small
cell lung cancer.